Defilade Capital Management, L.P.
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| PFIZER INC | $54.87M | 7.4% |
| AbbVie Inc. | $52.02M | 7.1% |
| NOVARTIS AG | $50.02M | 6.8% |
| ICU MEDICAL INC/DE | $48.61M | 6.6% |
| PACS Group, Inc. | $43.98M | 6.0% |
| ELI LILLY & Co | $34.34M | 4.7% |
| STERIS plc | $34.30M | 4.6% |
| Olema Pharmaceuticals, Inc. | $30.87M | 4.2% |
| Revolution Medicines, Inc. | $28.95M | 3.9% |
| BIOGEN INC. | $28.51M | 3.9% |
| Nuvalent, Inc. | $27.06M | 3.7% |
| Intuitive Surgical Inc | $25.86M | 3.5% |
| Henry Schein Inc | $24.22M | 3.3% |
| Globus Medical Inc | $23.33M | 3.2% |
| Xencor Inc | $21.66M | 2.9% |
| Cogent Biosciences, Inc. | $20.20M | 2.7% |
| Align Technology, Inc. | $20.00M | 2.7% |
| ASCENDIS PHARMA A/S | $18.27M | 2.5% |
| Dexcom Inc | $16.25M | 2.2% |
| Becton Dickinson & Co | $15.76M | 2.1% |
| AtriCure Inc | $15.73M | 2.1% |
| LivaNova PLC | $14.85M | 2.0% |
| Alphatec Holdings, Inc.ATEC | $13.19M | 1.8% |
| Denali Therapeutics Inc. | $10.84M | 1.5% |
| Glaukos Corp | $10.35M | 1.4% |
| RxSight, Inc. | $9.51M | 1.3% |
| Elanco Animal Health Inc | $9.08M | 1.2% |
| INSMED INC | $8.70M | 1.2% |
| Ocular Therapeutix, Inc | $8.28M | 1.1% |
| TELEFLEX INC | $5.23M | 0.7% |
| Eledon Pharmaceuticals, Inc. | $4.97M | 0.7% |
| CONMED Corp | $4.23M | 0.6% |
| Evommune, Inc.EVMN | $3.69M | 0.5% |